Nkgen Biotech Inc (NKGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NKGN Annual Balance Sheets →
From Nkgen Biotech Inc through Mar 31 2024, shifts in Mar 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent0.01
Cash & Short-term Investments0.00
Other Current Assets0.02
Prepaid Expense And Other Assets Current2.35
Total Current Assets2.38
Equipment/Property/Plant Net13.02
Other Assets, Noncurrent0.44
Restricted Cash Current0.02
Operating Lease Right Of Use Asset0.34
Total Assets15.84
Liabilities
Accounts Payable and Accrued Liabilities, Current LI16.74
Derivative Liability, Current DE0.18
Short-term Debt22.56
Other Liabilities, Current4.42
Total Current Liabilities43.89
Convertible Debt, Noncurrent LO11.08
Total Long-term Debt11.08
Derivative Liability, Noncurrent DE11.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.15
Deferred Income Tax Liabilities Net0.01
Operating Lease Liability Noncurrent0.21
Total Liabilities66.17
Stockholders' Equity
Common Stock Value0.01
Common Stock, Held by Subsidiary etc.-0.18
Additional Paid In Capital Common Stock140.91
Retained Earnings / Accumulated Deficit-191.07
Other Equity0.00
Common Stockholder's Equity-50.33
Total Stockholder's Equity-50.33
Liabilities & Stockholder's Equity15.84
4 historic quarters locked

Sign in to unlock the full Nkgen Biotech Inc balance sheet history.

About Nkgen Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001845459-26-000003

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.